Latest news in cancer
Brigatinib for ALK-positive crizotinib resistant non-small cell lung cancer
Dong-Wan Kim scholars from the Seoul National University Hospital in South Korea will give an oral report on the special meeting of metastatic non-small cell...
Proton therapy is the best option for lung cancer patients
Lung cancer and proton therapy The lungs are adjacent to some of the most sensitive and important organs and tissues, including the heart, esophagus, and...
Radiofrequency ablation treatment for lung cancer patients
Lung cancer is one of the most common causes of human death due to tumors, and its morbidity and mortality rate have ranked first in cities. The pathology is...
Afatinib is more effective than gefitinib in treating non-small cell lung cancer
The results of the LUX-Lung 7 study show that a head-to-head Phase IIb clinical study compared afatinib and gefitinib in the treatment of tumors with EGFR...
NCCN Guidelines for Small Cell Lung Cancer V2.2016
The second edition of the 2016 NCCN Guidelines for Small Cell Lung Cancer (V2.2016) mainly updates the following parts based on V2.2015: Lung cancer...
Nivolumab plus Ipilimumab as first-line treatment for stage IV non-small cell lung cancer
Registration: ClinicalTrials.gov Last updated: January 25, 2016 Main ID: NCT02659059 Registration Date: January 15, 2016 Main sponsor: Bristol-Myers Squibb...
Third-generation EGFR targeted drug Tagrisso for lung cancer treatment
The US FDA today approved the official launch of AstraZeneca’s new drug AZD9291! The trade name and common name of AZD9291 are called Tagrisso or...
Precision medicine for lung cancer
Lung cancer problem Perhaps it is because of the direct feeling of the respiratory system. As the haze continues, we feel more and more people suffering from...
EGFR monoclonal antibody Portrazza for advanced lung squamous cell carcinoma
The US Food and Drug Administration (hereinafter referred to as FDA) approved Portrazza (necitumumab) in combination with gemcitabine and cisplatin in the...
The safety and efficacy of MPDL3280A combined with platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer
MPDL3280A, which retains the PD-L2 / PD-1 interaction, potentially reduces autoimmune lung toxicity, and has a good effect on advanced NSCLC. Platinum-based...
Treatment of central lung cancer with speed knife
Treatment of non-small cell lung cancer The treatment of lung cancer mainly uses surgery, radiotherapy and chemotherapy, and surgery is still the most...
Non-small cell lung cancer with brain metastasis and ALK targeted therapy
Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases had a poor prognosis, with a median survival...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.